* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Wednesday, August 27, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Upload Season 4 Review – yahoo.com

    Upload Season 4 Review: A Thrilling New Chapter Unveiled

    ‘The Roses’ review: Olivia Colman, Benedict Cumberbatch sparkle in dark comedy – Yakima Herald-Republic

    The Roses’ Review: Olivia Colman and Benedict Cumberbatch Shine in Dark Comedy Delight

    ‘When Calls the Heart’ Fans All Want the Same Thing After Seeing the Show’s Latest Update – yahoo.com

    When Calls the Heart’ Fans Rally Together in Excitement Over Exciting New Update!

    Quotes of the Week: Peacemaker, Project Runway, Countdown and More – yahoo.com

    This Week’s Most Memorable Quotes from Peacemaker, Project Runway, Countdown, and More!

    Drake Appears in Teaser for Bobbi Althoff’s New Podcast ‘Not This Again’ – yahoo.com

    Drake Drops a Surprise Cameo in Bobbi Althoff’s Thrilling New Podcast Teaser ‘Not This Again

    From polka to Poison, Corn Palace adjusts entertainment offerings with the times – Mitchell Republic

    From polka to Poison, Corn Palace adjusts entertainment offerings with the times – Mitchell Republic

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    US-ROK Technology Cooperation Faces Rising Tensions – The National Interest

    Rising Tensions Put US-South Korea Technology Partnership to the Test

    The Role of AI and Technology in Shaping the Future of Interactive Entertainment – Technology Org

    How AI and Technology Are Transforming the Future of Interactive Entertainment

    Ten upcoming sports stadiums where technology takes to the field – Dezeen

    10 Futuristic Sports Stadiums Revolutionizing the Game with Cutting-Edge Technology

    Figure Technology Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering – Business Wire

    Figure Technology Solutions, Inc. Unveils Exciting Plans for Its Upcoming Initial Public Offering

    UNLV Responds to Workforce Need with Microcredential in Nuclear Technology – University of Nevada, Las Vegas | UNLV

    UNLV Unveils Cutting-Edge Microcredential Program to Fuel Growth in Nuclear Technology

    Why Technology Will Never Take Over Completely – Patheos

    Why Technology Will Never Completely Control Our Lives

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Upload Season 4 Review – yahoo.com

    Upload Season 4 Review: A Thrilling New Chapter Unveiled

    ‘The Roses’ review: Olivia Colman, Benedict Cumberbatch sparkle in dark comedy – Yakima Herald-Republic

    The Roses’ Review: Olivia Colman and Benedict Cumberbatch Shine in Dark Comedy Delight

    ‘When Calls the Heart’ Fans All Want the Same Thing After Seeing the Show’s Latest Update – yahoo.com

    When Calls the Heart’ Fans Rally Together in Excitement Over Exciting New Update!

    Quotes of the Week: Peacemaker, Project Runway, Countdown and More – yahoo.com

    This Week’s Most Memorable Quotes from Peacemaker, Project Runway, Countdown, and More!

    Drake Appears in Teaser for Bobbi Althoff’s New Podcast ‘Not This Again’ – yahoo.com

    Drake Drops a Surprise Cameo in Bobbi Althoff’s Thrilling New Podcast Teaser ‘Not This Again

    From polka to Poison, Corn Palace adjusts entertainment offerings with the times – Mitchell Republic

    From polka to Poison, Corn Palace adjusts entertainment offerings with the times – Mitchell Republic

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    US-ROK Technology Cooperation Faces Rising Tensions – The National Interest

    Rising Tensions Put US-South Korea Technology Partnership to the Test

    The Role of AI and Technology in Shaping the Future of Interactive Entertainment – Technology Org

    How AI and Technology Are Transforming the Future of Interactive Entertainment

    Ten upcoming sports stadiums where technology takes to the field – Dezeen

    10 Futuristic Sports Stadiums Revolutionizing the Game with Cutting-Edge Technology

    Figure Technology Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering – Business Wire

    Figure Technology Solutions, Inc. Unveils Exciting Plans for Its Upcoming Initial Public Offering

    UNLV Responds to Workforce Need with Microcredential in Nuclear Technology – University of Nevada, Las Vegas | UNLV

    UNLV Unveils Cutting-Edge Microcredential Program to Fuel Growth in Nuclear Technology

    Why Technology Will Never Take Over Completely – Patheos

    Why Technology Will Never Completely Control Our Lives

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Psychostimulant No Help in Relieving Cancer-Related Fatigue

May 23, 2024
in Health
Psychostimulant No Help in Relieving Cancer-Related Fatigue
Share on FacebookShare on Twitter

Six weeks of treatment with methylphenidate did no better than placebo for improving cancer-related fatigue (CRF).The results continued a pattern of inconsistency in outcomes of studies investigating psychostimulants for CRF.Changes in trial design and a focus on specific subpopulations might make additional studies worthwhile.

The psychostimulant methylphenidate proved no better than placebo for relieving cancer-related fatigue (CRF) in a randomized trial.

After 6 weeks of treatment in palliative care patients with advanced cancer, those allocated to methylphenidate had a 2-point greater improvement fatigue score as compared with placebo, a nonsignificant difference. After 10 weeks, the methylphenidate group still had only a nonsignificant improvement versus placebo.

Scores on quality-of-life (QoL) and symptom outcomes also did not differ between groups at 6 weeks, with the exception of a modest improvement in depression in the methylphenidate arm, reported Patrick Charles Stone, MD, of University College London, and coauthors in the Journal of Clinical Oncology.

“On the basis of our findings, we do not recommend the use (or further trials) of methylphenidate for fatigue in patients with advanced cancer receiving palliative care,” the authors concluded. “However, given the absence of major AEs [adverse events], it would be safe to continue to explore its use in future clinical trials for other symptoms (e.g., low mood or opioid-related drowsiness), in combination with other interventions (e.g., exercise or psychological therapies) or in different populations (e.g., post-treatment fatigue).”

The authors of an accompanying editorial agreed that the negative results should not close the door to future studies of methylphenidate or other psychostimulants.

“We believe there remains room for further trials in this area, particularly in subpopulations that have demonstrated promise, using measures that are sensitive to the specific aspect of fatigue that is most likely to demonstrate a benefit,” wrote Camilla Zimmerman, MD, PhD, of the University of Texas MD Anderson Cancer Center in Houston, and coauthors. “Considering the multifactorial nature of CRF, combination therapies of methylphenidate with other CRF treatments such as physical activity or cognitive behavioral therapy should also be considered.”

The study’s negative outcome continued a pattern of inconsistency with clinical trials of psychostimulants such as methylphenidate in patients with cancer or AIDS, owing in large part to challenges in trial design, William Breitbart, MD, of Memorial Sloan Kettering Cancer Center in New York City, told MedPage Today via email.

“Thus, we’ve seen several trials that show benefit and multiple trials that show no benefit,” said Breitbart, a member of the National Comprehensive Cancer Network (NCCN) Guidelines Panel for Cancer-Related Fatigue.

Challenges of such trials include:

Choosing a sufficiently severe fatigue threshold to allow adequate room for improvement in fatigue; the current study used>3 on a scale of 10Screening out patients with clinical depression to ensure the study assesses the effects of methylphenidate on cancer-related fatigue and not fatigue associated with depressionA study should focus on a homogeneous population (e.g., patients with prostate cancer treated with hormonal therapy); patients with advanced cancer have multiple potential causes of fatigue which might respond differently to methylphenidateThe placebo effect for a subjective symptom such as fatigue can be quite prolonged, and active drug and placebo may not separate for 4-6 weeks or more, so longer trials are necessaryAssessing fatigue with scales that focus only on subjective report — without studying cognitive effects and physical endurance effects, as well — reduces a multi-dimensional symptom to only one dimension, which may be insufficient to draw conclusions

“The NCCN Guidelines support the use of psychostimulants is not simply based on the published trials, but also on clinical judgment and expertise,” said Breitbart. “Clinicians utilize methylphenidate in clinical practice and often see benefits in fatigue. Treatment effects are often improved further if the underlying causes of fatigue can be simultaneously treated (e.g., anemia). However, a consensus of clinicians treating clinical fatigue in patients who are fatigued from cancer treatments of other etiologies find methylphenidate to be useful.”

Stone and colleagues noted that the NCCN “advises that methylphenidate can be considered in selected patients, but should be used cautiously and not until treatment and disease-specific morbidities have been characterized and excluded.” The guideline points out that optimal dosing and schedule have yet to be determined. Meanwhile, the European Society for Medical Oncology guideline on cancer-related fatigue “is noncommittal about the issue,” they wrote.

Given the ongoing uncertainty about methylphenidate’s effectiveness, the authors performed a placebo-controlled trial of individually titrated doses of the drug in patients with advanced cancer. The primary objective was fatigue scores after 6 weeks of treatment. Secondary outcomes included QoL, AEs, activities of daily living, appetite, patient satisfaction, survival, and need for other medications. Fatigue was assessed by means of the FACIT-F questionnaire, and significant baseline fatigue was defined as>3.

Data analysis included 159 patients (76 men, 83 women) who had a mean age of 63.7. The most common cancers in both groups were breast, lung, prostate, and lower gastrointestinal. Other baseline characteristics were balanced between the methylphenidate and placebo arms.

AEs had no discernible patterns to suggest greater harm from methylphenidate than placebo. A total of 25 serious AEs occurred in each arm.

After 6 weeks, the FACIT-F score in the methylphenidate group exceeded that of the placebo group by 1.97 (95% CI -0.95 to 4.90, P=0.186). A sensitivity analysis resulted in a difference of 2.05 in favor of methylphenidate, also nonsignificant. A threshold analysis produced a difference of 3.15 in favor of methylphenidate, still less than a minimally clinically important difference (MCID) of 5.

An analysis at 10 weeks showed a difference of 2.20 in favor of methylphenidate, still less than the MCID.

Mortality was similar in the two groups.

author['full_name']

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined MedPage Today in 2007. Follow

Disclosures

The study was supported by the UK National Institute for Health Research.

Stone had no relevant financial disclosures. Co-author Nick Freemantle disclosed relationships with Sanofi/Aventis, AstraZeneca, Thea, ALK, and Bloomsbury Therapeutixs.

Zimmermann is an associate editor of the Journal of Clinical Oncology. She disclosed a relationship with Pfizer.

Breitbart disclosed a relationship with Novartis.

Primary Source

Journal of Clinical Oncology

Source Reference: Stone PC, et al “Methylphenidate versus placebo for treating fatigue in patients with advanced cancer: Randomized, double-blind, multicenter, placebo-controlled trial” J Clin Oncol 2024; DOI: 10.1200/JCO.23.02639.

Secondary Source

Journal of Clinical Oncology

Source Reference: Chin-Yee N, et al “Putting methylphenidate for cancer-related fatigue to rest?” J Clin Oncol 2024; DOI: 10.1200/JCO.24.00707.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/hematologyoncology/othercancers/110281

Tags: healthPsychostimulantrelieving
Previous Post

The Morning Routine Jennifer Garner Swears By to Feel and Look Her Best at 52

Next Post

Nutrition Experts Call on Congress to Advance ‘Food Is Medicine’ Movement

Washington Department of Ecology Seeks Community Feedback on Drayton Harbor Cleanup Plan

August 27, 2025
Nebraska fairgoers learn about the science and art of circus at The Circus Science Spectacular – KSNB

Nebraska Fairgoers Dive into the Science and Art of Circus at The Circus Science Spectacular

August 27, 2025
Too much salt can hijack your brain – ScienceDaily

How Too Much Salt Hijacks Your Brain and Threatens Your Health

August 27, 2025
Oncologist warns ‘men are at higher risk of dying from cancer’; shares warning signs, lifestyle tips that can save lives | Health – Hindustan Times – Hindustan Times

Oncologist Reveals Why Men Face Higher Cancer Risks and Shares Life-Saving Warning Signs and Lifestyle Tips

August 27, 2025
US-ROK Technology Cooperation Faces Rising Tensions – The National Interest

Rising Tensions Put US-South Korea Technology Partnership to the Test

August 27, 2025
MATCH PREVIEW, pres. by Toyota: Red Bulls Battle the Columbus Crew on Saturday Night at Sports Illustrated Stadium – New York Red Bulls

MATCH PREVIEW, pres. by Toyota: Red Bulls Battle the Columbus Crew on Saturday Night at Sports Illustrated Stadium – New York Red Bulls

August 27, 2025
Researchers Build Real-World External Control Arm to Accelerate HER2+ Breast Cancer Drug Development – OncLive

Researchers Build Real-World External Control Arm to Accelerate HER2+ Breast Cancer Drug Development – OncLive

August 26, 2025
Stellantis paid $190.6 million in U.S. fuel economy penalties this year – Automotive News

Stellantis Hit with $190.6 Million in U.S. Fuel Economy Fines This Year

August 26, 2025
Upload Season 4 Review – yahoo.com

Upload Season 4 Review: A Thrilling New Chapter Unveiled

August 26, 2025
Hawaii Health Officials Say Lahaina Is Safe After 2023 Fire, but Tests Show Heavy Metal Exposure – U.S. News & World Report

Hawaii Health Officials Say Lahaina Is Safe After 2023 Fire, but Tests Show Heavy Metal Exposure – U.S. News & World Report

August 26, 2025

Categories

Archives

August 2025
MTWTFSS
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (792)
  • Economy (811)
  • Entertainment (21,690)
  • General (16,695)
  • Health (9,852)
  • Lifestyle (825)
  • News (22,149)
  • People (812)
  • Politics (819)
  • Science (16,022)
  • Sports (21,311)
  • Technology (15,792)
  • World (793)

Recent News

Washington Department of Ecology Seeks Community Feedback on Drayton Harbor Cleanup Plan

August 27, 2025
Nebraska fairgoers learn about the science and art of circus at The Circus Science Spectacular – KSNB

Nebraska Fairgoers Dive into the Science and Art of Circus at The Circus Science Spectacular

August 27, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version